Invega Sustenna 156mg/1ml recall: CGMP Deviations
INVEGA SUSTENNA 156MG/1ML; NDC/UPC 50458056301; RX; SYRINGES
Why was Invega Sustenna 156mg/1ml recalled?
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
KIB0M00
- Product
- INVEGA SUSTENNA 156MG/1ML; NDC/UPC 50458056301; RX; SYRINGES
- Recalling firm
- Cardinal Health Inc.
- Quantity
- 534 syringes
- Distribution
- FL, GA, SC
- Recall date
- June 2, 2021
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)